1. What is the Orange Healthcare PAPP-A Test?
It is a blood test that measures Pregnancy-Associated Plasma Protein A, a placental protein used primarily in first-trimester prenatal screening to assess the risk of certain chromosomal abnormalities.
2. Why is the PAPP-A Test performed?
The test is performed as part of first-trimester prenatal screening, commonly between 11 and 13 weeks plus 6 days of pregnancy, to help assess the risk of chromosomal conditions such as Down syndrome and Edwards syndrome.
3. What does a high PAPP-A result indicate?
PAPP-A levels normally increase as pregnancy progresses. An elevated value alone generally does not indicate a specific medical condition and must be interpreted according to gestational age and the laboratorys screening calculations.
4. What does a low PAPP-A result indicate?
Low PAPP-A levels may be associated with an increased screening risk of certain chromosomal abnormalities and placental complications, including fetal growth restriction and preeclampsia. However, a low result does not confirm any of these conditions.
5. Is fasting required for the Orange Healthcare PAPP-A Test?
Fasting is generally not required. Patients can usually eat and drink normally before sample collection. Accurate gestational age and relevant pregnancy details are important for interpreting the results.
6. What sample is required for the PAPP-A Test?
A blood sample is required. Serum is separated from the collected blood and analysed using a specialised immunoassay, commonly a chemiluminescent or time-resolved fluorescence immunoassay. Results are often expressed as multiples of the median (MoM) adjusted for gestational age and relevant maternal factors.